| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Issuance( Retirement)of Debt Net | -0.37 | -0.71 | -0.90 | -1.60 |
| Net Changein Cash | -6.75 | 0.09 | -22.09 | 31.75 |
| Cash Taxes Paid | 0.76 | -0.61 | -6.18 | 1.10 |
| Net Income/ Starting Line | -276.34 | -160.75 | -106.08 | -118.27 |
| Changesin Working Capital | -19.09 | 10.67 | 13.07 | 10.38 |
| Cashfrom Operating Activities | -301.41 | -154.10 | -115.47 | -103.15 |
| Cashfrom Financing Activities | 756.78 | -0.76 | -1.05 | 395.54 |
| Issuance( Retirement)of Stock Net | 755.98 | - | - | 397.40 |
| Depreciation/ Depletion | 5.61 | 5.31 | 5.82 | 5.83 |
| Other Investing Cash Flow Items Total | -457.03 | 192.23 | 94.44 | -257.75 |
| Capital Expenditures | -5.08 | -37.28 | - | -2.89 |
| period Type | - | - | - | - |
| Non- Cash Items | -11.60 | -9.34 | -28.27 | -1.09 |
| Financing Cash Flow Items | 1.18 | -0.05 | -0.16 | -0.26 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -462.11 | 154.95 | 94.44 | -260.65 |
| Cash Interest Paid | - | 0.05 | 0.16 | 0.26 |
Suven Life Sciences Dividend Suven Life Sciences Bonus Suven Life Sciences News Suven Life Sciences AGM Suven Life Sciences Rights Suven Life Sciences Splits Suven Life Sciences Board Meetings Suven Life Sciences Key Metrics Suven Life Sciences Shareholdings Suven Life Sciences Profit Loss Suven Life Sciences Balance Sheet Suven Life Sciences Q1 Results Suven Life Sciences Q2 Results Suven Life Sciences Q3 Results Suven Life Sciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.